SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-21-006408
Filing Date
2021-09-09
Accepted
2021-09-09 16:19:25
Documents
13
Period of Report
2021-09-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_090921.htm   iXBRL 8-K 22579
2 EXHIBIT 3.1 exh_31.htm EX-3.1 16831
  Complete submission text file 0001171843-21-006408.txt   217291

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE acst-20210907.xsd EX-101.SCH 3036
4 XBRL LABEL FILE acst-20210907_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE acst-20210907_pre.xml EX-101.PRE 22366
6 EXTRACTED XBRL INSTANCE DOCUMENT f8k_090921_htm.xml XML 3820
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-35776 | Film No.: 211244611
SIC: 2834 Pharmaceutical Preparations